Home NDC 68071-4856-2 Cefdinir
Product NDC 68071-4856
Requested package NDC 68071-4856-2
11-digit product format 680714856
Labeler code 68071
Product ID 68071-4856_3cd49451-feee-089c-e063-6294a90a7103
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Cefdinir
Dosage form CAPSULE
Route ORAL
Labeler NuCare Pharmaceuticals,Inc.
Application ANDA065264
Marketing category ANDA
Marketing start 2007-05-01
Substance CEFDINIR
Active strength 300 mg/1
Pharmacologic classes Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 13 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065264-001 CEFDINIR CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A065264-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A065264-001 CEFDINIR 300MG CAPSULE / ORAL AB 2006-05-19 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Cefdinir
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CEFDINIR 300 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination CI0FAO63WC Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 200346 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68071-4856-2 Cefdinir 20 in 1 BOTTLE CAPSULE 20 5 68071-4856-7 Cefdinir 14 in 1 BOTTLE CAPSULE 14 5
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 68071-4856-2 68071485602 20 CAPSULE in 1 BOTTLE (68071-4856-2) 20 capsule 2019-04-17 0000-00-00 No No Current